Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | MMP8 | P22894 | 1/20 | 0.50 |
| ▸ | MMP13 | P45452 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.45 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL5934814 | 0.98 | GAA (0.52) | GAACA1CA2MMP1MMP2 | |
| Ethylene Glycol SCHEMBL5555271 | 0.92 | GAA (0.46) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL9962546 | 0.84 | GAA (0.52) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL3887930 | 0.81 | ALDH1A1 (0.50) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL18890256 | 0.79 | GAA (0.52) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL12181562 | 0.79 | TLR9 (0.47) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL9755728 | 0.79 | GAA (0.46) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL13825727 | 0.79 | GAA (0.46) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL27914208 | 0.78 | GAA (0.56) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL13894485 | 0.77 | GAA (0.45) | GAACA1CA2MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8604231-B2 | Metal complexes for chemical vapour deposition of platinum | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-12-10 | — | — | US | disclosed |
| EP-2387626-B1 | ORGANOMETAL COMPLEXES FOR CHEMICAL VAPOUR DEPOSITION OF PLATINUM | CENTRE NAT RECH SCIENT (FR) | 2013-06-26 | — | — | EP | disclosed |
| US-20110294672-A1 | Metal Complexes for Chemical Vapour Deposition of Platinum | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2011-12-01 | — | — | US | disclosed |
| EP-2387626-A2 | METAL COMPLEXES FOR CHEMICAL VAPOUR DEPOSITION OF PLATINUM | Centre National De La Recherche Scientifique CNRS (FR) | 2011-11-23 | — | — | EP | disclosed |
| WO-2010081959-A2 | METAL COMPLEXES FOR CHEMICAL VAPOUR DEPOSITION OF PLATINUM | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-07-22 | — | — | WO | disclosed |
| US-20060128924-A1 | Novel condensation polymers from N, N*-disubstituted disulfonamides | PEWS R G | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294672-A1 | Metal Complexes for Chemical Vapour Deposition of Platinum | TIMCC, PDCD1, PDCD4 | GAA 4842/4885CA1 120/4885CA2 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.